Cationic protein-rich supernatants of cultured eosinophils from IL-2-treated patients have no cytotoxic activity on human renal cell carcinoma and melanoma cells: a preliminary report.
Moroni
M
M
Istituto di Terapia Medica, I.R.C.C.S. Policlinico San Matteo, Università degli Studi di Pavia, Italy.
Porta
C
C
Gritti
D
D
Di Amici
M
M
Giacobbe
O
O
Bobbio-Pallavicini
E
E
Notario
A
A
D000328:Adult; D001798:Blood Proteins / Q000032:analysis; D002292:Carcinoma, Renal Cell / Q000097:blood* / Q000628:therapy*; D002470:Cell Survival; D002478:Cells, Cultured; D047091:Eosinophil Granule Proteins; D047208:Eosinophil-Derived Neurotoxin; D004804:Eosinophils / Q000502:physiology*; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood; D007680:Kidney Neoplasms / Q000097:blood* / Q000628:therapy*; D008545:Melanoma; D010587:Phagocytosis; D011994:Recombinant Proteins / Q000627:therapeutic use; D012260:Ribonucleases; D014407:Tumor Cells, Cultured
D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D018836:Inflammation Mediators; D011994:Recombinant Proteins; D047208:Eosinophil-Derived Neurotoxin; D012260:Ribonucleases